Publication: 2218

Validation of Survival Prognostic Models for Non-Small-Cell Lung Cancer in Stage- and Age-specific Groups
      QxMD      Google Scholar   
Citation:
Lung Cancer vol 90 (2) 281-287
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
5
Parents:
1051  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA047577, CA33601, CA47577, 5R21AG042894, CA41287, U10 CA031946, U10 CA033601, R21 AG042894, U10 CA180821, U10CA180882, U10 CA041287, U10 CA047559, U10 CA180882, CA47559, P01 CA142538, U10CA180821, U10 CA180838, CA180821, CA31946  
Corr. Author:
 
Authors:
                       
Networks:
CARLE, LAPS-IL057, LAPS-NC010, NE003   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8834, CALGB-8836, CALGB-8931, CALGB-8932, CALGB-9132, CALGB-9532, CALGB-140202, CALGB-140203, CALGB-30203, CALGB-30303, CALGB-30402, CALGB-30406, CALGB-30506, CALGB-30704, CALGB-39802, CALGB-39809, CALGB-39904, CALGB-9238, CALGB-9335, CALGB-9633, CALGB-9730, CALGB-9731, CALGB-9761, Comprehensive
Phases:
1, 2, 3, N/A
Keywords:
Independent validation, Non-small cell lung cancer (NSCLC), Performance status, Prognostic models